Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
Guardado en:
Autores principales: | Mustafa Erman, Bivas Biswas, Pongwut Danchaivijitr, Lingwu Chen, Yoke Fui Wong, Tarek Hashem, Chun Sen Lim, Bulent Karabulut, Hsiao-Jen Chung, Chandrasekhar Chikatapu, Sara Ingles, Khemaies Slimane, Ravindran Kanesvaran |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4088abcfc2b4a2295bba6b69afcf827 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel P, et al.
Publicado: (2012) -
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
por: Peter E Clark
Publicado: (2010) -
Intra-Tumoral Pharmacokinetics of Pazopanib in Combination with Radiotherapy in Patients with Non-Metastatic Soft-Tissue Sarcoma
por: Laura Molenaar-Kuijsten, et al.
Publicado: (2021) -
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
por: Sewanti Limaye, et al.
Publicado: (2021) -
Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis.
por: Hisaki Aiba, et al.
Publicado: (2021)